Group 1 - The Hainan Free Trade Port has officially started operations, with Qionghai City launching a series of key projects to inject strong momentum into the first year post-closure [2][9] - A total of 72 projects have been signed, started, and put into production, with a total investment exceeding 30 billion yuan, covering various sectors including public services, ecological protection, infrastructure, and industrial development [8][9] - The Wenpo Community Agricultural Market project is nearing completion, with 90% of construction finished, expected to be operational before the Spring Festival, providing a comprehensive service hub for local residents [2] Group 2 - The Boao Lecheng International Medical Tourism Pilot Zone is gaining popularity among foreign patients, who appreciate the speed and cost-effectiveness of medical services available there [4][5] - Lecheng has introduced 553 licensed products, including 187 drugs and 353 medical devices, facilitating access to international medical resources for over 200,000 patients [7] - The recent approval of the Elecsys® pTau181 blood test for Alzheimer's disease marks a significant advancement in early diagnosis capabilities within the region [6] Group 3 - The construction of the Wenchang New Bridge, a key rural road project, is expected to alleviate traffic congestion and improve accessibility during flood seasons for 24,000 residents [3] - The recent capital connection meeting aims to support high-quality development for potential listed companies in the biopharmaceutical sector, leveraging the opportunities presented by the Hainan Free Trade Port [5][6] - The focus on diverse projects, including health industry parks and smart transportation centers, reflects a strategic approach to enhance the industrial structure and urban functionality in Qionghai [8][9]

在艾地苯醌落地瑞金海南医院之前，国内临床尚无获批的有效治疗手段，Leber遗传性视神经病变 的干预仅包括生活方式管理、遗传咨询和支持治疗。 依托"先行先试"政策，2025年12月下旬，瑞金海南医院成功引入艾地苯醌（规格150mg/片），成为 目前国内唯一实现该药物临床可及的医疗机构。 在得悉该药物在瑞金海南医院成功获批后，首批患者和家属第一时间通过瑞金海南医院特许药械医 患管理平台小程序提交预评估资料，随后专程赴上海瑞金医院眼科完成专业检查与评估，最终顺利来到 瑞金海南医院完成首次治疗。上海瑞金医院眼科副主任医师张琼在瑞金海南医院为首批患者提供了专业 细致的评估和指导。 治疗眼科罕见病Leber遗传性视神经病变创新药物在乐城开出全国首批处方 首批6名患者接受治疗 海南日报讯（海南日报全媒体记者 陈子仪 通讯员 张池）1月17日，6位Leber遗传性视神经病变 （LHON）患者同天内在上海交通大学医学院附属瑞金医院海南医院（海南博鳌研究型医院）（以下简 称瑞金海南医院）顺利完成特许药物艾地苯醌的治疗，成为中国首批受益于该创新药物的患者。 首批6位患者分别来自浙江、河北、安徽、广东、贵州等地。这些患者发病初期都有 ...